UNSPSC 51182501: Levothyroxine/liothyronine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS851. This VA Drug Class (HS851) classifies this compound as belonging to the group THYROID SUPPLEMENTS.

UNSPSC 51182501 Levothyroxine/liothyronine is a Commodity code covering thyroid hormone replacement pharmaceuticals that state and local governments procure for use in public health facilities, correctional institutions, and other government-operated medical settings. State and local buyers source these drugs through cooperative purchasing vehicles and multi-source pharmaceutical agreements that establish pricing and supply relationships with authorized wholesale distributors. The issuing bodies include state procurement offices administering multistate cooperative purchasing alliances and the member jurisdictions they serve — state agencies, counties, cities, and other local government entities that draw pharmaceuticals through the negotiated framework agreements rather than purchasing independently.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities in Minnesota, Oregon, and other member jurisdictions. The RFP is titled "MMCAP Generic Multi Source Pharmaceuticals and OTC Products," with proposals due March 26, 2026. Vendors must supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencara, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), maintain cGMP and Drug Supply Chain Security Act compliance, carry $5,000,000 commercial general liability insurance, and agree to a 3 percent administrative fee. Pricing carries 75 percent weight in evaluation, with compliance and EDI capability each weighted at 5 percent. Contract term is two years for new responders with optional extensions, effective July 1, 2026, and awarded vendors will be provided to wholesalers by May 15, 2026.